Siplizumab Antibody
Siplizumab (MEDI-507) is a humanized anti-CD2 monoclonal antibody that selectively depletes effector memory T cells while expanding regulatory T cells in vitro. This mechanism supports its investigation for treating T-cell-mediated conditions like plaque psoriasis, as evidenced in preclinical research.
Product Specifications
Product Name Alternative
MEDI507, MEDI-507, MEDI 507, Siplizumab
Target
Others, Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
12.45 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
147.24 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog